Literature DB >> 32840059

To estimate the safety and efficacy of a 3-D visualization helmet for vitreoretinal surgery.

Valerio Piccirillo1, Sandro Sbordone2, Francesco Sorgente1, Adele Ragucci2, Antonello Iovine1, Gennarfrancesco Iaccarino2, Michele Lanza2.   

Abstract

PURPOSE: To evaluate a 3-D visualization helmet (3DVH) during 23-gauge pars plana vitrectomy (PPV) for macular holes (MH) and macular puckers (MP).
METHODS: A total of 184 eyes of 184 patients undergoing PPV for MH or MP were randomly selected for surgery with 3DVH or standard Galilean microscope (GM). Only one highly trained surgeon performed each PPV. A surgical comfort score, ranging from 1 to 10 was recorded after each operation. Statistical analysis was run with SPSS to compare parameters before and after surgery and between the two groups.
RESULTS: No statistical differences were found between the two groups for mean best correct visual acuity improvement after surgery (p < 0.001). Mean surgery comfort evaluation was 7.63 ± 0.48 in 3DVH eyes and 8.21 ± 0.62 in GM ones (p = 0.09); mean overall surgical time was 35.12 ± 3.8 min in 3DVH eyes and 32.7 ± 2.27 min in GM ones (p < 0.001); mean peeling time was 14.24 ± 3.42 min in 3DVH eyes and 13.61 ± 4.63 min in GM ones (p = 0.11).
CONCLUSIONS: According to the data observed in this study, the 3DVH provides adequate safety and efficacy in retinal and macular visualization during PPV for MH and MP.
© 2020 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  epiretinal membrane; macular hole; macular surgery; vitrectomy 3D visualization system

Year:  2020        PMID: 32840059     DOI: 10.1111/aos.14591

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  1 in total

1.  Surgery-related characteristics, efficacy, safety and surgical team satisfaction of three-dimensional heads-up system versus traditional microscopic equipment for various vitreoretinal diseases.

Authors:  Xin-Yu Zhao; Qing Zhao; Ning-Ning Li; Li-Hui Meng; Wen-Fei Zhang; Er-Qian Wang; You-Xin Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-10-10       Impact factor: 3.535

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.